SCHEMBL29443232

SCHEMBL29443232

Cc1cccc2c(=O)[nH]c(CSC3CCCNCC3)nc12

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21073095 1.00 PARP14 (0.84) PARP14
SCHEMBL21127778 0.96 PARP14 (0.87) PARP14
Trifluoroacetic Acid SCHEMBL21072777 0.92 PARP14 (0.72) PARP14
SCHEMBL21072115 0.92 PARP14 (1.00) PARP14
SCHEMBL24923298 0.91 PARP14 (0.83) PARP14
SCHEMBL24923127 0.91 PARP14 (0.85) PARP14
Hydrochloric Acid SCHEMBL21072768 0.91 PARP14 (0.98) PARP14
SCHEMBL24923015 0.90 PARP14 (0.81) PARP14
SCHEMBL21073004 0.89 PARP14 (1.00) PARP14
Trifluoroacetic Acid SCHEMBL21072240 0.87 PARP14 (0.73) PARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117136060-A Methods of treating inflammatory diseases 里邦医疗公司 2023-11-28 CN claimed
CN-117136060-A Methods of treating inflammatory diseases 里邦医疗公司 2023-11-28 CN disclosed
CN-114206853-A Targeted protein degradation of PARP14 for therapy 里邦医疗公司 2022-03-18 CN disclosed